Inhibition of platelet aggregation by clopiclogrel is unaffected by the CYP2C19 681G>A polyrnorphism in patients with coronary artery disease

被引：0
|
作者：
Smith, Simon M. G. [1 ]
Buckland, Robert [1 ]
Daly, Martina E. [1 ]
Storey, Robert F. [1 ]
机构：
[1] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：375A / 375A
页数：1
相关论文
共 50 条
  • [1] Effect of CYP2C19 Genotype on Inhibition of Platelet Aggregation in Hemodialysis Patients With Coronary Artery Disease
    Waseda, Katsuhisa
    Saka, Yuki
    Takashima, Hiroaki
    Kurita, Akiyoshi
    Ando, Hirohiko
    Sakurai, Shinichiro
    Suzuki, Akihiro
    Sawada, Hiroaki
    Sato, Shigeko
    Nishikawa, Yoshinori
    Amano, Tetsuya
    CIRCULATION, 2016, 134
  • [2] Effect of CYP2C19 Genotype on Inhibition of Platelet Aggregation in Hemodialysis Patients With Coronary Artery Disease
    Waseda, Katsuhisa
    Saka, Yuki
    Takashima, Hiroaki
    Kurita, Akiyoshi
    Ando, Hirohiko
    Sakurai, Shinichiro
    Suzuki, Akihiro
    Sawada, Hiroaki
    Sato, Shigeko
    Nishikawa, Yoshinori
    Amano, Tetsuya
    CIRCULATION, 2016, 134
  • [3] Consistent and potent platelet inhibition of prasugrel irrespective of CYP2C19 polymorphism in Japanese patients with coronary artery disease
    Nishikawa, M.
    Isshiki, T.
    Ogawa, H.
    Kimura, T.
    Yokoi, H.
    Nanto, S.
    Takayama, M.
    Kitagawa, K.
    Miyazaki, S.
    Origasa, H.
    Sase, K.
    Umemura, K.
    Ikeda, Y.
    Yamaguchi, T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 336 - 336
  • [4] CYTOCHROME P450 2C19 681G>A POLYMORPHISM IN CORONARY HEART DISEASE PATIENTS TREATED WITH CLOPIDOGREL IN CHINESE
    Tang, Xiaofang
    Yuan, Jinqing
    Yang, Yuejin
    He, Chen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1206 - E1206
  • [5] CYP2C19 681G > A polymorphism and pharmacokinetics of clopidogrel in Chinese healthy volunteers
    Zou Jian-Jun
    Ding Li
    Tan Jie
    He BangShun
    Wang Guang-Ji
    Wang Shu-Kui
    PHARMAZIE, 2012, 67 (09): : 795 - 797
  • [6] The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A),*3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms
    Wojcik, Tomasz
    Karolko, Boiena
    Wisniewski, Jerzy
    Mysiak, Andrzej
    Sciborski, Krzysztof
    Onisk, Grzegorz
    Lebioda, Arleta
    Jonkisz, Anna
    Protasiewicz, Marcin
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2021, 17 (02): : 179 - 186
  • [7] Functional CYP2C19 Gene Variants are Associated With Both On-clopidogrel Platelet Adhesiveness and Aggregation in Japanese Patients With Coronary Artery Disease
    Kaikita, Koichi
    Ono, Takamichi
    Hokimoto, Seiji
    Tsujita, Kenichi
    Miyazaki, Yuji
    Sato, Koji
    Horio, Eiji
    Sumida, Hitoshi
    Sugiyama, Seigo
    Ogawa, Hisao
    CIRCULATION, 2010, 122 (21)
  • [8] The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel
    Tousoulis, Dimitris
    Siasos, Gerasimos
    Zaromitidou, Marina
    Oikonomou, Evangelos
    Maniatis, Konstantinos
    Kioufis, Stamatios
    Kokkou, Eleni
    Papavassiliou, Athanasios G.
    Stefanadis, Christodoulos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1594 - 1596
  • [9] Interaction of CYP2C19 G681A polymorphism and omeprazole on clopidogrel responsiveness and impact in patients with acute coronary syndrome
    Jirungda, Sornsith
    Pussadhamma, Burabha
    Komanasin, Nantarat
    Senthong, Vichai
    Leuangwatthananon, Wit
    CORONARY ARTERY DISEASE, 2020, 31 (03) : 266 - 272
  • [10] Prevalence and types of genetic polymorphisms of CYP2C19 and their effects on platelet aggregation inhibition by clopidogrel
    Aga, Q. A. A.
    Hasan, M. K.
    Nassir, K. F.
    Aga, L. A. A.
    Al-Jaidi, B. A.
    Aldhoun, M.
    Morsy, M. A.
    Nair, A. B.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (21) : 11286 - 11294
12345